Antimicrobial Resistance and Covid-19.

The major health emergencies observed during the recent years is coronavirus disease 2019 (COVID-19) pandemic and antimicrobial resistance (AMR). It has been found that along with COVID there is an outbreak of many other diseases. As their measures and consequences are comparable, the COVID-19 pandemic helps to demonstrate the potential prolonged impact of antimicrobial resistance, which is less acute but plays a vital determining role. They may also impact each other as there is a burden to use existing antimicrobials to treat critically ill COVID-19 patients in the absence of specific treatments. Shutdown/lockdowns and various other activities are followed world-wide to manage the spread of COVID-19 which may also lead to a slowdown in antimicrobial resistance. On-going trends like how COVID-19 affects antimicrobial resistance and what we can expect if this scenario remains the same or worsen will help us to plan the next steps for tackling antimicrobial resistance. To measure the impact of current COVID-19 policies and programs on antimicrobial resistance researchers should start collecting data.

Author(s): LeiliAghebati Malekibe

Abstract | Full-Text | PDF

Share This Article